Real-world effectiveness of Ad26.COV2.S or BNT162b2 booster vaccines against severe COVID-19 in adults who received a primary dose of Ad26.COV2.S in South Africa during the Delta p... by L Fairall, N Yende-Zuma, Tarylee Reddy, N Garrett, A Goga, S Bennet, N Folb, I Seocharan, S Mametja, M Semenya, S R N Simelane, L-G, G E Gray

Get full text